Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Junjun Li
Burning Rock Biotech
Learn more about SSRN Profiles
SCHOLARLY PAPERS
1
DOWNLOADS
60
TOTAL CITATIONS
0
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
Efficacy and Safety Comparisons of Programmed Cell Death-1 vs Programmed Cell Death Ligand-1 Inhibitors in Patients with Cancer: A Systematic Review and Updated Meta-Analysis
Number of pages: 32
Posted: 11 Dec 2023
Jun Yu
,
Qiaoxia Zhou
,
Guoqiang Wang
,
Hongwei Wang
,
Jinyu Yang
,
Xiaoran Sun
, Junjun Li,
Yezhen Shi
,
Jing Wang
,
Xiaofan Guo
,
Yiping Zou
,
Yongjie Xie
,
Zhou Zhang
,
Yuzi Zhang
,
Shangli Cai
and
Jihui Hao
Tianjin Medical University - Tianjin Key Laboratory of Cancer Prevention and Therapy, Burning Rock Biotech, Burning Rock Biotech - Department of Medicine, Tianjin Medical University, Burning Rock Biotech, Burning Rock Biotech, Burning Rock Biotech, Burning Rock Biotech, Burning Rock Biotech, Tianjin Medical University, Tianjin Medical University, Tianjin Medical University, Burning Rock Biotech, Burning Rock Biotech, Burning Rock Biotech - Department of Medicine and Tianjin Medical University - State Key Laboratory of Experimental Hematology
Downloads
60
(780,849)
View PDF
Download
Abstract:
PD-1, PD-L1, efficacy, safety, cancer
Feedback